NeuroScientific Biopharmaceuticals Ltd
ASX:NSB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NeuroScientific Biopharmaceuticals Ltd
ASX:NSB
|
AU |
|
O
|
Orora Ltd
OTC:ORRYY
|
AU |
|
EverQuote Inc
NASDAQ:EVER
|
US |
|
D
|
DaVita Inc
XMUN:TRL
|
US |
|
B
|
Basellandschaftliche Kantonalbank
LSE:0QQ4
|
CH |
|
M
|
Milner Consolidated Silver Mines Ltd
XTSX:MCA.H
|
CA |
|
D
|
Dotz Nano Ltd
F:57N
|
AU |
|
B
|
Bannerman Energy Ltd
F:BH6
|
AU |
|
A
|
Allianz SE
SWB:ALV
|
DE |
|
S
|
Sovereign Metals Ltd
F:SVM
|
AU |
|
W
|
Wawel SA
WSE:WWL
|
PL |
|
T
|
Trip.com Group Ltd
F:CLV
|
SG |
|
S
|
Sonic Automotive Inc
SWB:SA8A
|
US |
|
Tamboran Resources Corp
ASX:TBN
|
AU |
|
Touchstar PLC
LSE:TST
|
UK |
|
D
|
Deterra Royalties Ltd
OTC:DETRF
|
AU |
|
Yamaha Motor Co Ltd
F:YMA
|
JP |
|
Fluxys Belgium NV
XBRU:FLUX
|
BE |
|
Tencent Music Entertainment Group
LSE:0A2Z
|
CN |
|
A
|
Aplex Technology Inc
TPEX:6570
|
TW |
|
Konami Holdings Corp
TSE:9766
|
JP |
|
Cosmo Pharmaceuticals NV
OTC:CMOPF
|
IE |
|
F
|
FamiCord AG
F:V3V
|
DE |
|
D
|
Dr Martens PLC
OTC:DOCMF
|
UK |
Bankruptcy Probability
NeuroScientific Biopharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NeuroScientific Biopharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
NeuroScientific Biopharmaceuticals Ltd
ASX:NSB
|
22.6m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NeuroScientific Biopharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NeuroScientific Biopharmaceuticals Ltd has total debt of 38.7k AUD. This includes both short-term (0 AUD) and long-term (38.7k AUD) debt.
You can find a full breakdown on its Balance Sheet.